These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1559797)

  • 1. More insights into the mechanism(s) of the intravenous immunoglobulin effect in autoimmunity.
    Pollack S
    Isr J Med Sci; 1992 Feb; 28(2):130-2. PubMed ID: 1559797
    [No Abstract]   [Full Text] [Related]  

  • 2. Manipulating the immune system with immune globulin.
    Dwyer JM
    N Engl J Med; 1992 Jan; 326(2):107-16. PubMed ID: 1727218
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-idiotype suppression of autoimmunity by therapeutic intravenous immunoglobulins].
    Rossi F; Dietrich G; Kazatchkine M
    Ann Med Interne (Paris); 1988; 139(5):359-68. PubMed ID: 3144223
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results].
    Aymard JP; Ferry R; Janot C; Schooneman F; Streiff F
    Ann Med Interne (Paris); 1990; 141(8):689-97. PubMed ID: 2091513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous immunoglobulins in pediatrics].
    Fontán G
    An Esp Pediatr; 1986 Aug; 25(2):77-9. PubMed ID: 3752750
    [No Abstract]   [Full Text] [Related]  

  • 6. Innovative uses of intravenous immunoglobulins in clinical hematology. Symposium. December 5, 1986, San Francisco, California. Proceedings.
    Am J Med; 1987 Oct; 83(4A):1-56. PubMed ID: 3118702
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-idiotypic suppression of autoantibodies with high dose intravenous immunoglobulins.
    Kazatchkine MD
    Prog Clin Biol Res; 1990; 337():411-4. PubMed ID: 2112754
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulin therapy in immunohematological disorders.
    Choudhry VP; Mahapatra M; Kashyap R
    Indian J Pediatr; 1998; 65(5):681-90. PubMed ID: 10773923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-DNA idiotype (16/6 idiotype): pathogenic role in autoimmunity.
    Abu-Shakra M; Shoenfeld Y
    Hum Antibodies Hybridomas; 1990; 1(1):10-4. PubMed ID: 2103348
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-HLA antibodies (Ab1) and anti-idiotypic antibodies (Ab2) directed against Anti-HLA Ab1 in various preparations of polyspecific immunoglobulins for intravenous use].
    Barocci S; Fenoglio D; Leprini A; Nocera A
    Boll Soc Ital Biol Sper; 1990 Dec; 66(12):1193-200. PubMed ID: 2129237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immune cytopenias and some associated problems of immunohematology].
    Zotikov EA
    Biull Eksp Biol Med; 1996 Apr; 121(4):364-9. PubMed ID: 8829441
    [No Abstract]   [Full Text] [Related]  

  • 12. Successes and failures of intravenous immunoglobulin.
    Atrah HI; Crawford RJ; Gabra GS; Mitchell R
    Scand J Haematol; 1985 Apr; 34(4):345-7. PubMed ID: 4001865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulins and anti-idiotypic suppression of auto-immunity].
    Jobin D; Kazatchkine M
    Rev Med Interne; 1992; 13(2):162-5. PubMed ID: 1410893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous gammaglobulin in the treatment of humoral immunodeficiency disease and autoimmune hematologic disease.
    Bussel JB; Cunningham-Rundles C
    Ration Drug Ther; 1984 Jul; 18(7):1-6. PubMed ID: 6085405
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.
    Ronda N; Kaveri SV; Kazatchkine MD
    Clin Exp Immunol; 1993 Sep; 93 Suppl 1(Suppl 1):14-5. PubMed ID: 8365019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current problems in immunohematology].
    Ricci C; Blefari D
    Minerva Med; 1971 May; 62(38):1934-40. PubMed ID: 4103283
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment modalities of autoimmune blood disorders.
    Collins PW; Newland AC
    Semin Hematol; 1992 Jan; 29(1):64-74. PubMed ID: 1570545
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.
    Brand A; Van Doorn PA; Rossi F; Kazatchkine MD; Vermeulen M
    Prog Clin Biol Res; 1990; 337():405-9. PubMed ID: 2353004
    [No Abstract]   [Full Text] [Related]  

  • 19. [The cause of the secondary reaction in the intravenous use of administered immunoglobulin].
    Geursen RG; Kroh U; Krump W; Scharfe B
    Beitr Infusionther Klin Ernahr; 1982; 9():95-114. PubMed ID: 6756385
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.